Medicine News and Research

RSS

MSU receives $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant

A team of researchers from Michigan State University and the University of Cincinnati have been awarded a $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant.

15 Oct 2009

Handwashing with soap is the best way to control flu and respiratory infections

People are more likely to wash their hands when they have been shamed into it, according to a study by the London School of Hygiene & Tropical Medicine

15 Oct 2009

Illness for uninsured adults in the United States nearing retirement age spells financial disaster: Study

For the more than four million uninsured adults in the United States nearing retirement age, a serious illness often spells financial disaster, according to a recent study.

15 Oct 2009

Diet and exercise program unlikely to eliminate OSA in overweight patients

A study in the Oct. 15 issue of the Journal of Clinical Sleep Medicine found that while a strict diet and exercise program may benefit obese patients with mild to moderate obstructive sleep apnea (OSA), it is unlikely to eliminate the condition.

15 Oct 2009

Human populations may have some level of existing immunity to the pandemic H1N1 influenza, say researchers

University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years. These molecular sites appear to result in some level of immunity to the new virus in people who were exposed to the earlier influenza viruses.

15 Oct 2009

Hoag Memorial Hospital implements PCTS' Amelior EDTracker software

Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc., today announced that Hoag Memorial Hospital Presbyterian has implemented the company's Amelior EDTracker® solution to automatically track patients in its 66,000-census emergency department.

15 Oct 2009

Required flu vaccines for New York health workers draws criticism

The New York Civil Liberties Union is criticizing a regulation that requires hundreds of thousands of state health workers to get both seasonal and swine flu vaccinations. Critics say it violates workers' right to decide their own medical treatment.

15 Oct 2009

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

NYU Langone Medical Center has received a five-year, $10 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center for the Neuroscience of Mental Disorders. The center, named after the late Silvio O. Conte, a U.S. congressman and advocate for mental health research, will study the onset of schizophrenia. Schizophrenia is a disease with cognitive dysfunction, affecting approximately one percent of the population worldwide.

15 Oct 2009

Much remains to be done for autism spectrum disorders, say experts

Scientific understanding and medical treatments for autism spectrum disorders (ASDs) have advanced significantly over the past several years, but much remains to be done, say experts from the Center for Autism Research at The Children's Hospital of Philadelphia who published a scientific review of the field today.

15 Oct 2009

AAPA welcomes Senate Finance Committee's vote to approve the America's Healthy Future Act

The American Academy of Physician Assistants (AAPA), representing 75,000 clinically practicing physician assistants (PAs) in the United States, applauds the Senate Finance Committee's vote to approve the America's Healthy Future Act. AAPA is committed to seeking health care reform legislation that provides the American people with access to quality, affordable, cost-effective health care.

15 Oct 2009

Genetic diversity thwarts the usefulness of malaria vaccine

Researchers at the University of Maryland School of Medicine Center for Vaccine Development (CVD) have charted the extreme genetic differences that occur over time in the most dangerous malaria parasite in the world. While there is no approved vaccine for malaria, various experimental vaccines are in development.

15 Oct 2009

More than half RCTs do not report vital information about study populations race, says study

A new study recently published online by the American Heart Journal shows that more than half of all randomized clinical trials, or RCTs, for cardiovascular disease are not reporting vital information about the study populations race or ethnicity. NYU School of Medicine researchers found that out of the 156 cardiovascular disease RCTs analyzed, only 35% of trials reported any information on race or ethnicity between 1970 and 2006. From 2000 to 2006, 46% of trials included that information.

15 Oct 2009

Online medical journal to be launched

Two Johns Hopkins Children's Center researchers have assembled a 25-member editorial board of international experts to launch a quarterly online medical journal devoted to original research and commentary on the use of computer automation in the day-to-day practice of medicine.

15 Oct 2009

Surveillance of travel-related illness helps to detect and respond to H1N1 influenza

Because pandemics unfold in unpredictable ways, surveillance of travel-related illness is among the most powerful tools health officials and doctors can use to detect and respond to new pathogens like the novel H1N1 influenza, says the physician who heads the University of Alabama at Birmingham (UAB) Travelers' Clinic.

15 Oct 2009

Institute of Medicine elects two new members from St. Jude Children's Research Hospital

Michael Kastan, M.D., Ph.D., and Mary Relling, Pharm.D., of St. Jude Children's Research Hospital, have been elected to the Institute of Medicine (IOM), a prestigious branch of the National Academy of Sciences.

15 Oct 2009

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K. Shinseki decided to establish a service-connection for Vietnam Veterans with three specific illnesses based on the latest evidence of an association with the herbicides referred to as Agent Orange.

15 Oct 2009

DNA Precision offers services for genetic research and healthcare research

DNA Precision has begun offering services for genetic research and healthcare research. These include gene discovery, Agilent ® microarray processing and bioinformatics. DNA Precision is a division of EcoArray, Inc., a 7-year old environmental genomics firm in Gainesville, FL.

15 Oct 2009

Postive vote from FDA Advisory Committee for Fampridine-SR 10

Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.

15 Oct 2009

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.

14 Oct 2009

Medicine News and Research

MSU receives $6.2 million Morris K. Udall Center of Excellence for Parkinson's disease grant

Handwashing with soap is the best way to control flu and respiratory infections

Illness for uninsured adults in the United States nearing retirement age spells financial disaster: Study

Diet and exercise program unlikely to eliminate OSA in overweight patients

Human populations may have some level of existing immunity to the pandemic H1N1 influenza, say researchers

Hoag Memorial Hospital implements PCTS' Amelior EDTracker software

Required flu vaccines for New York health workers draws criticism

NYU Langone Medical Center to establish a schizophrenia research center with $10M NIMH grant

Much remains to be done for autism spectrum disorders, say experts

AAPA welcomes Senate Finance Committee's vote to approve the America's Healthy Future Act

Genetic diversity thwarts the usefulness of malaria vaccine

More than half RCTs do not report vital information about study populations race, says study

Online medical journal to be launched

Surveillance of travel-related illness helps to detect and respond to H1N1 influenza

Institute of Medicine elects two new members from St. Jude Children's Research Hospital

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

DNA Precision offers services for genetic research and healthcare research

Postive vote from FDA Advisory Committee for Fampridine-SR 10

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News